Should ConnectiveRx prioritize expanding its patient support programs or focus on enhancing its digital adherence solutions for pharmaceutical clients?

Introduction

The trade-off question at hand is whether ConnectiveRx should prioritize expanding its patient support programs or focus on enhancing its digital adherence solutions for pharmaceutical clients. This scenario involves balancing direct patient services with B2B offerings for pharma companies. I'll approach this analysis by examining the business context, user impact, technical considerations, and resource allocation to determine the most strategic path forward.

Step 1

Clarifying Questions (3 minutes)

• Context: I'm thinking our current market position might influence this decision. Could you share how ConnectiveRx is currently performing in terms of market share and revenue growth?

Why it matters: Helps determine if we need to focus on consolidating our position or aggressively expanding Expected answer: Steady growth but facing increased competition Impact on approach: Would influence whether we prioritize short-term gains or long-term strategic positioning

• Business Context: Based on industry trends, I'm assuming digital adherence solutions are becoming increasingly important. How do our pharmaceutical clients currently view the importance of these solutions compared to traditional patient support programs?

Why it matters: Indicates where client demand and potential revenue growth lie Expected answer: Growing interest in digital solutions, but still strong demand for comprehensive patient support Impact on approach: Would help balance resource allocation between the two areas

• User Impact: Considering patient outcomes, I'm curious about the effectiveness of our current support programs versus digital adherence solutions. Do we have any data on patient engagement and adherence rates for each?

Why it matters: Helps prioritize based on actual impact on patient health outcomes Expected answer: Both show positive impacts, but digital solutions might have more scalable results Impact on approach: Would influence which area to emphasize for maximum patient benefit

• Technical: Given the rapid advancements in health tech, I'm wondering about our current technical capabilities. How easily can we scale and enhance our digital adherence solutions with our existing infrastructure?

Why it matters: Determines the feasibility and timeline for improving digital offerings Expected answer: Solid foundation but would require significant investment to lead the market Impact on approach: Would affect the balance between immediate expansion and long-term development

• Resource: Considering the dual focus, I'm thinking about team capacity. How are our product and development teams currently split between patient support programs and digital solutions?

Why it matters: Indicates where we have existing expertise and where we might need to build capacity Expected answer: More resources currently allocated to patient support programs Impact on approach: Would influence whether we need to hire, train, or reallocate teams